Ambrisentan-induced severe asymptomatic thrombocytopenia

Kigitovica, Dana; Šablinskis, Matiss; Lejniece, Sandra; Lejnieks, Aivars; Skride, Andris

Journal Metrics

Impact Factor (2022): 1.3
5-Year Impact Factor: 1.5
Eigenfactor Score: 0.00148
CiteScore (2022): 1.9
SCImago Journal Rank: 0.29

28/4Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and institutes

In titles and abstracts

In keywords

In all

pdf

Ambrisentan-induced severe asymptomatic thrombocytopenia [Anatol J Cardiol]

Anatol J Cardiol. 2020; 24(4): 285-286 | DOI: 10.14744/AnatolJCardiol.2020.91376

Ambrisentan-induced severe asymptomatic thrombocytopenia

Dana Kigitovica¹, Matiss Šablinskis², Sandra Lejniece¹, Aivars Lejnieks¹, Andris Skride¹
¹Department of Internal Diseases, Riga Stradins University; Riga-Latvia
²Medical Faculty, Riga Stradins University; Riga-Latvia

Keywords: Pulmonary arterial hypertension, Ambrisentan, Thrombocytopenia

Dana Kigitovica, Matiss Šablinskis, Sandra Lejniece, Aivars Lejnieks, Andris Skride. Ambrisentan-induced severe asymptomatic thrombocytopenia. Anatol J Cardiol. 2020; 24(4): 285-286

Corresponding Author: Andris Skride, Latvia
Manuscript Language: English

TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author Similar articles PubMed Google Scholar